FARAPULSE
Total Payments
$279,791
Transactions
18
Doctors
8
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $250,000 | 1 | 0 |
| 2022 | $29,791 | 17 | 8 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $250,000 | 1 | 89.4% |
| Consulting Fee | $22,250 | 5 | 8.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,000 | 1 | 1.4% |
| Travel and Lodging | $3,483 | 10 | 1.2% |
| Food and Beverage | $58.52 | 1 | 0.0% |
Payments by Type
Research
$250,000
1 transactions
General
$29,791
17 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Posterior Wall Substrate Modification Using Irreversible Electroporation for the Treatment of Paroxysmal Atrial Fibrillation | Boston Scientific Corporation | $250,000 | 0 |
Top Doctors Receiving Payments for FARAPULSE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Boston, MA | $250,000 | 1 |
| , MD | Internal Medicine | Beachwood, OH | $5,654 | 3 |
| , D.O | Cardiovascular Disease | West Des Moines, IA | $5,443 | 3 |
| , MD | Clinical Cardiac Electrophysiology | West Des Moines, IA | $5,107 | 4 |
| , M.D | Clinical Cardiac Electrophysiology | Chicago, IL | $4,930 | 3 |
| , MD | Cardiovascular Disease | Cleveland, OH | $4,500 | 1 |
| , M.D | Clinical Cardiac Electrophysiology | New York, NY | $4,000 | 1 |
| , MD | Cardiovascular Disease | San Diego, CA | $97.61 | 1 |
| , M.D | Internal Medicine | Santa Monica, CA | $58.52 | 1 |
Ad
Manufacturing Companies
- Boston Scientific Corporation $279,791
Product Information
- Type Device
- Total Payments $279,791
- Total Doctors 8
- Transactions 18
About FARAPULSE
FARAPULSE is a device associated with $279,791 in payments to 8 healthcare providers, recorded across 18 transactions in the CMS Open Payments database. The primary manufacturer is Boston Scientific Corporation.
Payment data is available from 2022 to 2024. In 2024, $250,000 was paid across 1 transactions to 0 doctors.
The most common payment nature for FARAPULSE is "Unspecified" ($250,000, 89.4% of total).
FARAPULSE is associated with 1 research study, including "Posterior Wall Substrate Modification Using Irreversible Electroporation for the Treatment of Paroxysmal Atrial Fibrillation" ($250,000).